My Photo

« | Main | Epidemiology of Hepatitis B »

January 27, 2010


Feed You can follow this conversation by subscribing to the comment feed for this post.

Joseph S. Galati, M.D.

Update: We are actively enrolling patients for several hepatitis C studies. As noted above, this will be naive genotype 1 individuals, as well as those previously treated with any of the PEG-Interferon and ribavirin combinations. This would include therapy with PEG-Intron and well as Pegasys.

Enrollment is starting now. Contact Herman Ortiz at Research Specialists of Texas at 713-794-0700.

The comments to this entry are closed.